ASS1 and pancreatic neoplasm: Preclinical study found that arginine depletion using pegylated arginine deiminase (ADI-PEG20) selectively inhibited the proliferation of ASS1-deficient pancreatic cancer cells and enhanced radiotherapy-induced apoptosis 49.